Search

Start typing to see results...

Today Market

Stock Performance

Today Market

Today's High

78,509.77

Todday's Low

78,048.26

Open at

78,509.77

Previous Close

78,542.44

Volumes

Avg Price

-388.19

Historical Performance

News

10 Aug 26
Mankind Pharma appoints Anish Bafna as Independent Director for a five-year term
Mankind Pharma Limited announced the appointment of Mr. Anish Vanraj Bafna as an Additional Director, designated as a Non-Executive Independent Director, effective August 10, 2026.
10 Aug 26
Mankind Pharma appoints Anish Bafna as Independent Director for a five-year term
Mankind Pharma Limited announced the appointment of Mr. Anish Vanraj Bafna as an Additional Director, designated as a Non-Executive Independent Director, effective August 10, 2026.
10 Aug 26
Mankind Pharma appoints Anish Bafna as Non-Executive Independent Director for 5 years
Mankind Pharma Limited announced the appointment of Mr. Anish Vanraj Bafna as an Additional Director, designated as a Non-Executive Independent Director, effective August 10, 2026.
30 Jul 26
Mankind Pharma’s revenue from operations rose 12.9% to INR 4,031 crore in Q1 2026
Mankind Pharma (BSE: 543904 | NSE: MANKIND) announced its financial results for the first quarter ended June 30, 2026, reporting revenue from operations of INR 4,031 crore, a 12.

Historical Prices

Share Price Chart

Historical Share Price

Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
11-08-26 2429.00 2439.60 2405.50 2425.00 229702 18184 556572937.30 24471.70
10-08-26 2450.00 2485.00 2428.50 2438.00 230964 15131 565013510.00 24583.80
07-08-26 2430.00 2456.00 2415.60 2456.00 167663 10876 408812908.80 24570.65
06-08-26 2450.00 2463.80 2420.30 2420.30 241909 14467 590294167.70 24636.00
05-08-26 2461.00 2461.90 2435.00 2435.60 157619 12049 385869868.20 24624.65
04-08-26 2483.00 2487.00 2438.00 2438.00 346444 13969 854317345.80 24614.90
03-08-26 2458.00 2497.90 2442.20 2483.00 639674 29159 1584447378.50 24774.30
31-07-26 2604.00 2613.50 2422.00 2469.60 2362283 104667 5807402951.30 24383.60
30-07-26 2585.30 2605.00 2560.50 2575.90 294648 25808 760706312.10 24317.15
29-07-26 2627.90 2642.00 2583.00 2592.70 309498 22683 808840734.20 24250.20

Fundamentals

Company Valuation

Market Cap (₹cr)

100688.42

PE Ratio

44.52

PB Ratio

6.14

Dividend Yield

0.04

ROE

13.27

ROCE

13.07

Book Value (₹)

397.024678

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 74921805 18.14 74921805 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 225038807 54.49 225038807 3
Others 0 0.00 0 0
Sub Total 299960612 72.63 299960612 13
Total ShareHolding for Promoter & Group 299960612 72.63 299960612 13
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 8400 0.00 8400 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 39041918 9.45 39041918 501
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6358592 1.54 6358592 17
Mutual Funds / UTI 44889663 10.87 44889663 36
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 12299126 2.98 12299126 25
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 102597699 24.84 102597699 581
plus  Non Institution
Bodies Corporate 4287989 1.04 4287989 598
Clearing Members 199392 0.05 199392 3
Directors & their Relatives 0 0.00 0 0
Employees 196682 0.05 196682 14
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 213336 0.05 213336 2832
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 187319 0.05 187319 3198
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 5321321 1.29 5321321 159467
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4715 0.00 4715 8
Others 26913 0.01 26913 1
Sub Total 10437667 2.53 10437667 166121
Total Public Shareholding 113035366 27.37 113035366 166702
Total of Promoter & Public ShareHolding 412995978 100.00 412995978 166715
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 412995978 100.00 412995978 166715

Financials (₹ in cr)

Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales14,277.6412,207.4410,260.448,749.437,781.56
OPM (%)17.2520.6123.3719.1025.38
OP2,462.432,516.332,397.941,671.241,974.60
Other Income358.79536.79280.22128.57196.03
PBIDT3,858.143,566.962,809.112,041.632,199.83
INTEREST639.28429.4132.7544.4758.61
PBDT3,218.863,137.552,776.361,997.162,141.22
PBT2,202.932,516.332,397.941,671.241,974.60
EO-129.750.000.000.000.00
PBT after EO2,332.682,516.332,397.941,671.241,974.60
TAXES394.58509.74457.15361.56521.64
PAT1,912.931,990.961,912.901,281.861,433.48
EPS46.2849.1947.6832.0035.78
Raw Material16.0316.5217.9620.7326.44
Power and Fuel1.291.221.221.251.33
Employee Cost22.3022.0622.0321.9320.83
Other Manufacturing Expenses0.000.000.000.000.00
Selling and Administration Expenses19.4519.9818.2318.4818.12
Miscellaneous Expenses1.081.341.231.741.57
Revenue (Growth %) 16.9618.9817.2712.4425.22
PBIDT (Growth %)8.1626.9837.59-7.1920.16
PAT (Growth %) -3.924.0849.23-10.5813.28
PBIDT (Margin %)27.0229.2227.3823.3328.27
PAT (Margin %) 13.4016.3118.6414.6518.42

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 41.2841.2640.0640.0640.0640.06
Reserves Total 16355.6614281.469662.717743.856500.394694.21
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds16396.9414322.729702.777783.916540.454734.27
Secured Loans 5488.265444.2714.930.00623.6695.00
Unsecured Loans 82.521938.788.574.6964.235.85
Total Debt5570.787383.0523.504.69687.89100.85
Other Liabilities225.97131.37124.73109.0489.0262.92
Total Liabilities22193.6921837.149851.007897.647317.364898.04
APPLICATION OF FUNDS :
Gross Block 5891.355658.484578.233775.593292.311227.09
Less : Accumulated Depreciation 1965.541582.511026.67633.37365.62239.68
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 3925.814075.973551.563142.222926.69987.41
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress420.04207.43209.44494.78386.57165.57
Producing Properties0.000.000.000.000.000.00
Investments 16523.1516683.384215.363102.232525.872396.89
Current Assets, Loans & Advances
Inventories 1087.841097.941126.031032.221266.69826.91
Sundry Debtors 1163.63908.71769.04492.64470.59369.17
Cash and Bank Balance159.22306.26483.88155.15138.85476.95
Loans and Advances 724.00848.931011.09775.441070.80520.92
Total Current Assets3134.693161.843390.042455.452946.922193.95
Less : Current Liabilities and Provisions
Current Liabilities 1726.662036.401179.711080.011319.07789.20
Provisions 704.96567.37419.30337.61266.74193.08
Total Current Liabilities & Provisions2431.622603.771599.011417.621585.81982.28
Net Current Assets703.07558.071791.031037.831361.111211.66
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets464.76398.21358.15263.37165.26122.49
Deferred Tax Liability291.30415.53424.53319.23200.79109.45
Net Deferred Tax173.46-17.32-66.38-55.86-35.5313.04
Other Assets448.16329.61149.99176.45152.67123.47
Total Assets22193.6921837.149851.007897.657317.374898.04
Contingent Liabilities1123.831193.31247.0078.72135.2415.79

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities 578.63-710.41-4.739,816.50-2,476.92
Investing Activities -1,360.27-1,040.61-1,665.19-12,177.60-388.09
Net Cash Flow 39.8147.9666.16-10.96-113.02
Operating Activities 821.441,798.991,736.082,350.142,751.99

Corporate Actions

DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
RCJ
RAMESH CHAND JUNEJA
Chairman & Wholetime Director
Executive
RJ
RAJEEV JUNEJA
Vice Chairman & Managing Director
Executive
SA
SHEETAL ARORA
Whole Time Director & Chief Executive Officer
Executive
Functional Directors
SKS
SATISH KUMAR SHARMA
Whole-time Director
WTD
Independent Directors
TPO
TILOKCHAND PUNAMCHAND OSTWAL
Independent Director
Ind.
BA
Bharat Anand
Independent Director
Ind.
VK
Vivek Kalra
Independent Director
Ind.
VS
Vijaya Sampath
Independent Director
Ind.
Other Officials
HKJ
Hitesh Kumar Jain
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Mankind Pharma Ltd?

Mankind Pharma Ltd trades on NSE under MANKIND and on BSE under code 543904. The ISIN is INE634S01028 and the face value is Rs 1.

What is the share price of Mankind Pharma Ltd today? +

As of 11 August 2026, Mankind Pharma Ltd trades at Rs 2,425.00, a change of -13.00 (-0.53%) on the day. Prices are live and subject to change.

What is the market capitalisation of Mankind Pharma Ltd? +

As of 11 August 2026, Mankind Pharma Ltd has a market cap of about Rs 100688.42 crore. This figure is live and moves with the share price.

Is Mankind Pharma Ltd profitable? +

In March 2026, Mankind Pharma Ltd reported a profit after tax of Rs 1,912.93 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Mankind Pharma Ltd? +

: As of 11 August 2026, the PE (TTM) for Mankind Pharma Ltd is 44.52 and the price-to-book ratio is 6.14. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Mankind Pharma Ltd pay a dividend? +

As of 11 August 2026, the dividend yield for Mankind Pharma Ltd is 0.04%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Mankind Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 72.63% of Mankind Pharma Ltd. Public shareholding is 27.37%, including mutual funds at 10.87% and foreign institutional investors at 9.45%.

What were the latest annual financials of Mankind Pharma Ltd? +

In March 2026, Mankind Pharma Ltd reported net sales of Rs 14,277.64 crore, revenue growth of 16.96%, and earnings per share of Rs 46.28.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web